NJ Challenge To Drug Subsidy Cuts

23 June 1996

A New Jersey Assembly committee has decided that the governor and the state administration overstepped their authority with proposals to cut costs in the drug subsidy program for seniors and the disabled.

The vote will not block the rule changes (which will cut fees to pharmacists who take part in the program, increase the amount of generics dispensed and encourage seniors to buy their prescriptions through the mail) but will send a message to Governor Whitman and the state Department of Human Services to listen to legislators and their older constituents. The proposals are intended to save $22.5 million, with most savings coming from cutting back fees paid to druggists from about $4 to about $3.25 per prescription.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight